Trial · NCT03103074
Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa
NCT03103074, Not applicable, Completed, University Hospital of North Norway
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa. Trials, record NCT03103074. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03103074
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa
- NCT number
- NCT03103074
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 20 participants, actual
- Lead sponsor
- University Hospital of North Norway
- Conditions
- Hidradenitis Suppurativa
- Interventions
- Botulinum B Toxin, Placebo Saline
- First posted
- 2017-04-06
- Last updated
- 2018-10-25
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Patient reported improvement after invention with Botulinum toxin B | End point analysis 6 months | Outcome measured by Dermatological Life Quality Index (DLQI)-scores |
| Secondary | Identification of clinical subgroups with best response to intervention as assessed by clinically scored measures | Interim analysis after 6 weeks- 3 months. End point analysis 6 months and sub group analysis 12 months | Registration and analysis on investigator scored measures assessed by Hidradenitis suppurativa score (HiSCR) in relation to clinical phenotypes (location, Hurley stage) |
| Secondary | Identify if covariates such as age, disease duration, smoking state, BMI and sweating influence patient reported improvement | Interim analysis after 6 weeks- 3 months. End point analysis 6 months and sub group analysis 12 months | Covariate analysis on patient recorded DLQI in relation to pre-registered variables |
| Secondary | Identification of clinical subgroups with best response to intervention as assessed by patient reported improvement | Interim analysis after 6 weeks- 3 months. End point analysis 6 months and sub group analysis 12 months | Registration and analysis on patient recorded DLQI in relation to clinical phenotypes (location, Hurley stage) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 32761500 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03103074
GET https://conductscience.org/api/trials/v1/NCT03103074/registered